The U.S. drug crisis does not appear to be letting up. The nation experienced a shattering 47,000 opioid-related overdose deaths in 2017. Driving the surge are potent, cheap synthetics like fentanyl. They've spread into the illicit drug supply, and in response communities have been trying a range of interventions, from increasing naloxone trainings to upping treatment resources. But a new analysis from policy think tank, the Rand Corporation, concludes it's time to pilot an approach from outside the U.S.: offering pharmaceutical-grade heroin — yes, heroin — as a form of treatment for long time heroin users who haven't had success with other treatments. It's already happening in several European countries and Canada . But it would challenge culture,...
READ MORE >
Is America Ready For Prescription Heroin?